Adapthealth Corp Financials
AHCO Stock | USD 9.95 0.17 1.68% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 0.89 | 1.2086 |
|
|
Investors should never underestimate Adapthealth Corp's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Adapthealth Corp's cash flow, debt, and profitability to make informed and accurate decisions about investing in Adapthealth Corp.
Net Income |
|
Adapthealth | Select Account or Indicator |
Understanding current and past Adapthealth Corp Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Adapthealth Corp's financial statements are interrelated, with each one affecting the others. For example, an increase in Adapthealth Corp's assets may result in an increase in income on the income statement.
Adapthealth Corp Stock Summary
Adapthealth Corp competes with Axogen, Artivion, Integer Holdings, Paragon 28, and LivaNova PLC. AdaptHealth Corp., together with its subsidiaries, provides home medical equipment , medical supplies, and home and related services in the United States. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania. Adapthealth Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 10700 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US00653Q1022 |
CUSIP | 00653Q102 23291E109 23291E208 |
Location | Pennsylvania; U.S.A |
Business Address | 220 West Germantown |
Sector | Health Care Providers & Services |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | adapthealth.com |
Phone | 610 424 4515 |
Currency | USD - US Dollar |
Adapthealth Corp Key Financial Ratios
Return On Equity | -0.13 | ||||
Profit Margin | (0.07) % | ||||
Operating Margin | 0.09 % | ||||
Price To Sales | 0.41 X | ||||
Revenue | 3.2 B |
Adapthealth Corp Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 227.8M | 1.8B | 5.3B | 5.2B | 4.5B | 2.7B | |
Other Current Liab | 23.3M | 174.0M | 102.4M | 98.3M | 156.8M | 87.3M | |
Other Liab | 29.3M | 209.0M | 380.3M | 344.0M | 395.6M | 415.4M | |
Net Tangible Assets | (290.2M) | (696.5M) | (1.6B) | (1.6B) | (1.4B) | (1.3B) | |
Net Debt | 151.6M | 707.0M | 2.2B | 2.3B | 2.2B | 1.2B | |
Retained Earnings | (74.8M) | (91.1M) | (43.0M) | 26.3M | (652.6M) | (620.0M) | |
Accounts Payable | 26.5M | 191.0M | 248.0M | 222.5M | 211.5M | 141.4M | |
Cash | 9.8M | 100.0M | 149.6M | 46.3M | 77.1M | 60.3M | |
Other Assets | 34.8M | 224.9M | 319.3M | 300.5M | 345.5M | 362.8M | |
Long Term Debt | 395.1M | 776.6M | 2.2B | 2.2B | 2.1B | 1.2B | |
Net Receivables | 27.0M | 171.1M | 359.9M | 359.1M | 388.9M | 217.5M | |
Good Will | 110.4M | 1.0B | 3.5B | 3.5B | 2.7B | 1.7B | |
Capital Surpluse | 2.9M | 11.3M | 558.5M | 2.1B | 2.4B | 2.5B | |
Inventory | 18.2M | 58.8M | 123.1M | 127.8M | 113.6M | 71.4M | |
Total Liab | 212.7M | 1.4B | 3.2B | 3.1B | 3.0B | 1.7B | |
Net Invested Capital | 382.3M | 1.2B | 2.2B | 2.2B | 3.6B | 3.8B | |
Short Long Term Debt | 1.7M | 8.1M | 20M | 35M | 53.4M | 56.0M | |
Total Current Assets | 58.1M | 372.8M | 670.1M | 585.3M | 649.0M | 367.2M | |
Net Working Capital | 30.5M | (58.8M) | 170.2M | 129.1M | 112.0M | 60.2M | |
Short Term Debt | 1.7M | 52.7M | 113.7M | 99.4M | 130.2M | 136.7M | |
Common Stock | 240.6M | 7.2K | 9K | 13K | 11.7K | 11.1K | |
Other Current Assets | 3.2M | 33.4M | 74.9M | 52.1M | 69.3M | 42.7M |
Adapthealth Corp Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 13.3M | 41.4M | 95.2M | 109.4M | 130.3M | 136.8M | |
Total Revenue | 529.6M | 1.1B | 2.5B | 3.0B | 3.2B | 3.4B | |
Gross Profit | 89.8M | 161.2M | 445.6M | 417.4M | 479.6M | 503.5M | |
Operating Income | 29.7M | 74.8M | 225.6M | 190.4M | (598.4M) | (568.5M) | |
Ebit | 29.7M | (164.6M) | 150.5M | 207.3M | (591.7M) | (562.1M) | |
Cost Of Revenue | 439.8M | 895.2M | 2.0B | 2.6B | 2.7B | 2.9B | |
Income Before Tax | 12.5M | (70.7M) | 191.0M | 97.9M | (723.8M) | (687.6M) | |
Net Income | 12.2M | (58.7M) | 156.2M | 69.3M | (678.9M) | (645.0M) | |
Income Tax Expense | 294K | (12.0M) | 32.8M | 24.8M | (49.0M) | (46.6M) | |
Minority Interest | (14.7M) | (23.6M) | (2.0M) | (3.8M) | (4.2M) | (4.4M) | |
Ebitda | 37.1M | (82.2M) | 483.7M | 630.8M | (171.1M) | (162.5M) | |
Tax Provision | 1.2M | (12.0M) | 32.8M | 24.8M | (26.2M) | (24.9M) | |
Net Interest Income | (39.3M) | (41.4M) | (95.2M) | (109.4M) | (127.3M) | (121.0M) |
Adapthealth Corp Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change To Inventory | (14.3M) | (19.4M) | (14.9M) | (6.3M) | 15.5M | 16.3M | |
Change In Cash | (875K) | 23.1M | 49.7M | (103.4M) | 30.9M | 32.4M | |
Net Borrowings | 185.7M | 354.7M | 1.4B | (36.2M) | (41.6M) | (39.5M) | |
Free Cash Flow | 39.1M | 155.9M | 72.4M | (17.6M) | 143.2M | 150.4M | |
Depreciation | 11.3M | 82.4M | 258.1M | 351.2M | 420.6M | 441.6M | |
Other Non Cash Items | 43.1M | 97.4M | (34.9M) | 17.1M | 804.2M | 844.4M | |
Capital Expenditures | 21.3M | 39.8M | 203.3M | 391.4M | 337.5M | 354.3M | |
Net Income | 12.2M | (58.7M) | 158.2M | 73.1M | (678.9M) | (645.0M) | |
End Period Cash Flow | 9.8M | 100.0M | 149.6M | 46.3M | 77.1M | 53.3M | |
Change To Netincome | 28.4M | 93.6M | 3.4M | 56.1M | 64.6M | 34.2M | |
Investments | (84.9M) | (815.7M) | (1.1M) | (411.2M) | (412.7M) | (433.3M) |
Adapthealth Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Adapthealth Corp's current stock value. Our valuation model uses many indicators to compare Adapthealth Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Adapthealth Corp competition to find correlations between indicators driving Adapthealth Corp's intrinsic value. More Info.Adapthealth Corp is rated below average in return on equity category among its peers. It is rated fourth in return on asset category among its peers . At this time, Adapthealth Corp's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Adapthealth Corp's earnings, one of the primary drivers of an investment's value.Adapthealth Corp Systematic Risk
Adapthealth Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Adapthealth Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Adapthealth Corp correlated with the market. If Beta is less than 0 Adapthealth Corp generally moves in the opposite direction as compared to the market. If Adapthealth Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Adapthealth Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Adapthealth Corp is generally in the same direction as the market. If Beta > 1 Adapthealth Corp moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Adapthealth Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Adapthealth Corp's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Adapthealth Corp growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Adapthealth Corp November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Adapthealth Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Adapthealth Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Adapthealth Corp based on widely used predictive technical indicators. In general, we focus on analyzing Adapthealth Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Adapthealth Corp's daily price indicators and compare them against related drivers.
Information Ratio | (0.05) | |||
Maximum Drawdown | 17.61 | |||
Value At Risk | (4.46) | |||
Potential Upside | 4.77 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adapthealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Adapthealth Stock, please use our How to Invest in Adapthealth Corp guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adapthealth Corp. If investors know Adapthealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adapthealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.444 | Earnings Share (1.67) | Revenue Per Share 24.465 | Quarterly Revenue Growth 0.002 | Return On Assets 0.0411 |
The market value of Adapthealth Corp is measured differently than its book value, which is the value of Adapthealth that is recorded on the company's balance sheet. Investors also form their own opinion of Adapthealth Corp's value that differs from its market value or its book value, called intrinsic value, which is Adapthealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adapthealth Corp's market value can be influenced by many factors that don't directly affect Adapthealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adapthealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adapthealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adapthealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.